Implantable medical devices market was valued at $91,868.94 million in 2020, and is estimated to reach $179.0 Billion by 2030, growing at a CAGR of 7.2% from 2021 to 2030. An implant is a medical device, which is used to replace or support any damaged body organs, improve the functioning of body organs, or treat defects in normal body functions. These can be surgically implanted either permanently or temporarily in the human body, and can be removed when dispensable. These implantable devices comprise bones, tissues, skin, ceramics, metals, plastics, and other natural materials. Medical implants are used to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
CONMED Corporation, Abbott Laboratories, Globus Medical, Inc., C. R. Bard, Inc., Cardinal Health, Inc., LivaNova PLC, Integra LifeSciences Holdings Corporation, Biotronik SE and Co. KG, Boston Scientific Corporation, Johnson and Johnson
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/492
The implantable medical devices market is segmented on the basis of product and region. By product, the implantable medical devices market size is categorized into orthopedic implants, dental implants, breast implants, cardiovascular implants, intraocular lenses, and other implants. The orthopedic implants are further classified as spinal implants and reconstructive joint replacements. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of product, the global implantable medical devices market is classified into orthopedic implants, dental implants, breast implants, cardiovascular implants, intraocular lenses, and other implants. The other implants segment was the major implantable medical devices market size to the global market in 2020, and is anticipated to remain dominant during the forecast period due to technological advancements in the implantable medical devices, increase in adoption of implantable medical devices, rise in incidence rate of chronic cardiovascular diseases, and surge in number of advanced and effective product launches.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/492
North America accounted for major share of the global implantable medical devices market share in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to increase in incidences of chronic diseases, surge in demand for implantable medical devices, availability of advanced healthcare facilities with trained medical professionals, rise in number of R&D activities coupled with large presence of key players, and surge in investment made by governments in the healthcare system. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period. Moreover, Japan and China are expected to grow at high CAGR in Asia-Pacific implantable medical devices market majorly due to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced instruments, development of the R&D sector, upsurge in healthcare reforms, and technological advancements in the field of implants.
๐๐๐๐๐๐- ๐ ๐๐ฎ๐๐ฌ๐๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง-๐๐๐ฌ๐๐ ๐๐ข๐๐ซ๐๐ซ๐ฒ (๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐จ๐ง-๐๐๐ฆ๐๐ง๐, ๐ฌ๐ฎ๐๐ฌ๐๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง-๐๐๐ฌ๐๐ ๐ฉ๐ซ๐ข๐๐ข๐ง๐ ๐ฆ๐จ๐๐๐ฅ) ๐๐๐๐๐ซ๐๐ ๐๐ฒ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
๐๐๐ญ ๐๐ง ๐๐๐๐๐ฌ๐ฌ ๐ญ๐จ ๐ญ๐ก๐ ๐ฅ๐ข๐๐ซ๐๐ซ๐ฒ ๐จ๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ญ ๐๐ง๐ฒ ๐ญ๐ข๐ฆ๐ ๐๐ซ๐จ๐ฆ ๐๐ง๐ฒ ๐๐๐ฏ๐ข๐๐ ๐๐ง๐ ๐๐ง๐ฒ๐ฐ๐ก๐๐ซ๐. ๐ ๐จ๐ซ ๐ฆ๐จ๐ซ๐ ๐๐๐ญ๐๐ข๐ฅ๐ฌ, ๐๐จ๐ฅ๐ฅ๐จ๐ฐ ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค: https://www.alliedmarketresearch.com/library-access
๐๐๐จ๐ฎ๐ญ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Market Research
+1 800-792-5285
Visit us on social media:
Transparency Market Research (TMR) has published a new report titled, โImplantable Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019โ2027โ.
In terms of volume, the implantable medical devices were accounted atย 10,712,732ย units inย 2018.Request Brochure โhttps://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=13946OverviewAn implantable device, according to the U.S. FDA, is โa device that is placed into a surgically or naturally formed cavity of the human body, if it is intended to remain there for a period of 30 days or moreโ.Metals and their alloys have been utilized in the manufacture of implants since the development of first implantable deviceRise in demand for minimally invasive procedures, aging population, high obesity rates, and high purchasing power of the population are anticipated to drive demand for implantable medical devices during the forecast period.North America dominated the global implantable medical devices market inย 2018ย and the trend is anticipated to continue during the forecast period.
Well-established health care infrastructure, availability of reimbursements, and introduction of the Affordable Care Act in the U.S. are expected to drive the market in North America.Asia Pacific is likely to be a highly lucrative market for implantable medical devices and it is expected to expand at a high CAGR during the forecast periodRequest COVID Analysis on Implantable Medical Devices Market โย https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=13946Rise in Demand for Minimally Invasive Procedures to Driven the MarketPatients prefer minimally invasive surgery as it includes lesser post-surgery complications and side effects, and shorter recovery time.
Therefore, minimal invasive nature of interventional cardiology acts as a driver of the marketThe minimal invasive nature of these surgery procedures influences the decision making of patients to undergo interventional cardiac treatmentsOrthopedic Implants Segment Accounted for Significant Market ShareIn terms of product type, the global implantable medical devices market has been segmented into orthopedic implants, dental implants and cardiovascular implants.
The reconstructive joint replacement segment is further divide into shoulder implants, elbow implants, ankle implants, hip implants, and knee implantsThe orthopedic implants segment is expected to continue to lead the market fromย 2019toย 2027ย due to increase in geriatric population, changing lifestyles leading to a high prevalence of obesity and high acceptance of implants such as knee & hip reconstructive joint replacement implantsRequest Customization on Implantable Medical Devices Market Report โhttps://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=13946Titanium Segment Accounted for Significant Market ShareIn terms of material, the global implantable medical devices market has been segmented into stainless steel, cobalt chromium (CoCr) alloy titanium, titanium alloy, and zirconiumThe titanium segment held the largest share of the global implantable medical devices market in terms of revenue inย 2018owing to increase in utilization of titanium in the implantable productsClinics to be Promising SegmentIn terms of end-user, the global implantable medical devices market has been classified into hospitals, ambulatory surgical centers, and clinics.
The hospitals segment is categorized into +500 beds, 200-499 beds and less than 200 bedsGrowth of the hospitals segment can be attributed to the high preference among patients for their implantation surgeries within a hospital and presence of large number of hospitals providing implantation facilities especially in some of the developed countriesNorth America to Dominate Global MarketIn terms of region, the global implantable medical devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Active implantable medical devices market size is set to reach $28.8 billion by 2023, growing at a CAGR of 8.0% between 2017-2023.
Technological advancements, increasing prevalence of cardiovascular diseases, increasing healthcare expenditures and rising research and development activities are the major factors driving the growth of the market.The R investments for the development of novel and innovative active implantable medical devices are increasing due to increased demand for effective implantable medical devices.
Moreover, the currently available devices require surgical implantation and replacement surgeries after every few years.
The technologically advanced implantable medical devices facilitate non-invasive procedures for the safe and effective treatment of drug-resistant neurological disorders.
Many companies in the active implantable medical devices market such as Medtronic Inc., Boston Scientific Corporation, LivaNova plc, William Demant Holding AG and Cochlear Ltd. are actively involved in the development of new and advanced active implantable devices.Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/active-implantable-medical-devices-market/report-sampleThe Asia-Pacific active implantable medical devices market is expected to grow at the fastest rate in the forecast period as compared to other regions, mainly due to growing aging population in various countries, such as India and China.
Moreover, the substantially larger base of the aging population in these Asian countries, is expected to drive the growth of the active implantable medical device market in the region.
